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The use of human pluripotent stem cells for labora-
tory studies and cell-based therapies is hampered
by their tumor-forming potential and limited ability
to generate pure populations of differentiated cell
types in vitro. To address these issues, we estab-
lished endodermal progenitor (EP) cell lines from
human embryonic and induced pluripotent stem
cells. Optimized growth conditions were established
that allow near unlimited (>1016) EP cell self-renewal
in which they display amorphology and gene expres-
sion pattern characteristic of definitive endoderm.
Upon manipulation of their culture conditions
in vitro or transplantation into mice, clonally derived
EP cells differentiate into numerous endodermal line-
ages, including monohormonal glucose-responsive
pancreatic b-cells, hepatocytes, and intestinal
epithelia. Importantly, EP cells are nontumorigenic
in vivo. Thus, EP cells represent a powerful tool to
study endoderm specification and offer a potentially
safe source of endodermal-derived tissues for trans-
plantation therapies.
INTRODUCTION
Human pluripotent stem cells (PSCs), including embryonic stem
cells (ESCs) and induced pluripotent stem cells (iPSCs), hold
tremendous promise for both basic biology and cell-based ther-
apies due to their unlimited in vitro proliferation capacity and
their potential to generate all tissue types (Murry and Keller,
2008; Stadtfeld and Hochedlinger, 2010). Upon in vitro differen-
tiation, these stem cell populations recapitulate early embryonic
development, giving rise to a spectrum of mature cell types
(Murry and Keller, 2008).
Duringembryogenesis, theblastocyst inner cellmassgives rise
to an epithelial population known as the epiblast. These cells tra-
verse the primitive streak during gastrulation, giving rise tomeso-derm and definitive endoderm (DE) (Lu et al., 2001). The epithelial
sheet of nascent DE then folds to form the primitive gut tube con-
sisting of three major domains along the anterior-posterior axis:
the foregut, midgut, and hindgut. These domains are further
refined into specific regions from which the rudiments of various
endodermal organs bud (Zorn and Wells, 2009). The foregut
eventually gives rise to esophagus, trachea, lungs, thyroid, para-
thyroid, thymus, stomach, liver, biliary system, and pancreas,
while the midgut and hindgut form the small intestine and colon.
Endodermal-derived tissues, including liver and pancreas, are
potentially useful for cell replacement therapies. It is possible to
generate DE and its derivative lineages from PSCs in vitro
through sequential exposure to cytokines that mimics that in
embryonic morphogenesis. In this fashion, hepatic, intestinal,
and pancreatic cells can be produced from ESCs and iPSCs
(D’Amour et al., 2006; Gouon-Evans et al., 2006; Basma et al.,
2009; Spence et al., 2011a). While these studies highlight the
promise of PSC-derived endodermal tissues for transplantation
therapies, several obstacles remain. Endodermal cells gener-
ated from PSCs tend to display immature phenotypes and in
many instances are not fully functional. For example, most
pancreatic b-cells currently generated in vitro from human
ESCs are polyhormonal and not glucose responsive (D’Amour
et al., 2006; Nostro et al., 2011). In addition, the pluripotent
nature of ESCs and iPSCs results in production of multiple cells
types from different germ layers inmost differentiation protocols.
Thus, it is difficult to produce pure monolineage cultures of
a desired cell type from PSCs (Murry and Keller, 2008). Finally,
undifferentiated ESCs and iPSCs are tumorigenic and therefore
must be completely removed from their derivative tissues to be
used for transplantation (Hentze et al., 2009).
To address these issues, we generated self-renewing DE
progenitor lines from both human ESCs and iPSCs. These cells,
termed EP cells for endodermal progenitor cells, display a pro-
liferative capacity similar to ESCs yet lack teratoma-forming
ability. In addition, EP cell lines generate endodermal tissues
representing liver, pancreas, and intestine, both in vitro and
in vivo. Thus, EP cell lines provide a powerful reagent to study
how different gut tissues are specified from a common multi-
potent endodermal progenitor and to optimize monolineageCell Stem Cell 10, 371–384, April 6, 2012 ª2012 Elsevier Inc. 371
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Figure 1. A Putative Definitive Endoderm Progenitor Population Is Identified in Differentiation Cultures from Human ESCs
The human ESC line H9 was differentiated toward the hepatic lineage.
(A) Phase contrast image of a culture maintained for 4 weeks shows two distinct types of populations (Differentiated versus Progenitor). The scale bar represents
100 mm. Image was captured with a 203 objective.
(B) Colony types indicated in (A) were manually picked and pooled into groups, and gene expression was analyzed by quantitative real-time RT-PCR, comparing
to undifferentiated ESCs. ES, embryonic stem cells; Diff, differentiated cells; Prog, progenitor colonies. The expression of indicated genes is shown normalized
to the housekeeping gene PPIG. Values represent the mean of three individual pools of each population. Error bars represent the standard errors.
(C) Cultures were assayed for CD117 (KIT) versus CXCR4, SOX17 versus FOXA1, and SOX17 versus CXCR4 by flow cytometry in three separate stains.
See also Table S4.
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may represent a strategy to optimize the production of pure,
nontumorigenic cells for tissue replacement therapies.
RESULTS
Identification of a Definitive Endoderm Progenitor
Population from Human PSCs
We adapted a step-wise differentiation protocol in serum free
media that was previously shown to induce DE and its derivative
hepatic lineages from mouse and human ESCs (Gadue et al.,
2006; Gouon-Evans et al., 2006). This protocol uses Activin A
to induce DE and then BMP4 and basic FGF (bFGF) among other
factors to specify a hepatic fate fromDE in a process that mimics
embryogenesis. Using a variation of this protocol (see Experi-
mental Procedures), we could generate hepatic cells after
2 weeks of induction (data not shown). Interestingly, after 3–
4 weeks, these cultures contained two cell populations with
distinct morphology (Figure 1A). One population resembled372 Cell Stem Cell 10, 371–384, April 6, 2012 ª2012 Elsevier Inc.immature hepatocytes, being large and highly vacuolated (Fig-
ure 1A, ‘‘Differentiated Cells’’), while the other population resem-
bled undifferentiated ESC colonies (Figure 1A, ‘‘Progenitor
Colonies’’). These mixed cultures maintained both colony types
after passaging for over 9 months (data not shown). We used
a pipette to manually isolate colonies of a given morphology
and performed gene expression analysis using QRT-PCR (Fig-
ure 1B). The ESC markers NANOG and OCT4 were not ex-
pressed in either cell type, suggesting that these colonies were
not an outgrowth of contaminating ESCs in the culture. The early
hepatocyte marker AFP was enriched in the differentiated colo-
nies while the early panendoderm marker SOX17 was enriched
in the putative progenitor colonies. The early endoderm/liver/
pancreas marker HNF4A (Duncan et al., 1997) was found in
both. Based on these findings, we hypothesized that the undif-
ferentiated colonies might represent EP cells undergoing both
self-renewal and differentiation into hepatocytes in culture.
The bulk differentiation cultures were then examined by flow
cytometry for expression of KIT (CD117) and CXCR4, which
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Figure 2. Purification and Maintenance of Endodermal Progenitor Cells
(A) Cultures containing endoderm progenitors as in Figure 1 were sorted based upon CXCR4 expression. Gene expression was analyzed by QRT-PCR. CXCR4+
cells were cultured as in Figure 1 and after 1 or 3 passages, cultures were assayed for SOX17 versus FOXA1 expression by intracellular flow cytometry.
(B) EP cell lines are established by sorting definitive endoderm (CXCR4+CD117high) cells from day 5 of human ESC differentiation cultures inducedwith high levels
of Activin A, and culturing the cells in optimized conditions (see text). Images show typical morphology of EP cell colonies (H9-EP), captured using 103 and 203
objectives.
(C) EP cell lines derived from H9 ESCs or iPSCs were cultured and cell growth was analyzed by cell count at each passage. Left panel: graph shows relative cell
growth over time (Square: iPSC2-derived EP cell line; Circle: H9-derived EP cell line). Right panel: SOX17 versus FOXA1 expression by intracellular flow cytometry
after either 24 (H9-EP) or 20 (iPSC2-EP) passages.
See also Figures S1 and S2 and Tables S1–S4.
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D’Amour et al., 2005). A subpopulation of CXCR4+CD117+ cells
(3%–60%) was consistently present in the cultures (Figure 1C
and data not shown). These double-positive cells also express
the panendoderm marker FOXA1 (Ang et al., 1993) and
SOX17, which is expressed transiently in immature endoderm
in vivo (Kanai-Azuma et al., 2002).
The CXCR4+CD117+FOXA1+SOX17+ population likely marks
putative EP cells from the undifferentiated colonies, which we
showed to be enriched for SOX17 mRNA (Figure 1B). To test
this, we used FACS to isolate CXCR4+ and CXCR4 cells for
further study. The early hepatocyte marker AFP was enriched
in the CXCR4 cells while the CXCR4+ population expressed
the immature endoderm marker SOX17 and was negative for
AFP expression (Figure 2A). Purified CXCR4+ cells could be
expanded in culture, but within three passages, reverted toa mixed population containing both SOX17+ and SOX17 cells,
indicative of differentiation in culture (Figure 2A, right panel).
In contrast, the CXCR4 population had little proliferative
capacity, consistent with a more mature phenotype of differenti-
ated hepatocytes in vitro (data not shown).
Our data indicate that self-renewing EP cells can be
produced through in vitro manipulation of human ESCs. Differ-
entiation of CXCR4+ EP cells into AFP-expressing hepatocytes
was expected in our initial experiments (Figure 1) because the
culture conditions were initially formulated to drive hepatocyte
differentiation (Gouon-Evans et al., 2006). To better expand
the EP cell population while maintaining the FOXA1+SOX17+
phenotype of these cells, we identified culture conditions, which
consist of a serum free media containing BMP4, bFGF, EGF,
and VEGF plated on matrigel and MEF feeders (see Experi-
mental Procedures). Utilizing matrigel was critical becauseCell Stem Cell 10, 371–384, April 6, 2012 ª2012 Elsevier Inc. 373
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Figure 3. Gene Expression Microarray Analyses of EP Cells Compared to ESCs and Transient Definitive Endoderm
(A–C) Purified ESCs (sorted SSEA3high SSEA4high), transient endoderm (day 5 high Activin-treated, sorted CXCR4high CD117high), and EP cells (sorted CXCR4high
CD117high) were analyzed using gene expression microarrays. T0, ESCs; T5, transient endoderm; EPC, EP cells. (A) ESC, transient endodermal cell, and EP cell
global expression profile clustered by dendrogram. (B) Principal component analysis of populations in (A). (C) Heat map expression levels of genes related to
pluripotency, primitive streak/mesendoderm, definitive endoderm, and cell surface markers.
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shown).
Using these optimized culture conditions, we developed
a simplified protocol for EP cell production. Human ESCs or
iPSCs were induced to differentiate in the presence of high
Activin A, which promotes endoderm formation (D’Amour
et al., 2005). Definitive endoderm cells (CXCR4+CD117+) were
purified by cell sorting and cultured directly in EP cell medium
(Figure 2B, left panel). When cultured in the optimized condi-
tions, the majority of cells form epithelial structures reminiscent
of gut epithelium and contain what appears to be a central
lumen, especially at higher cell density (Figure 2B, right panel).
Both ESC-derived and iPSC-derived EP cell lines proliferated
extensively and displayed a homogenous EP cell phenotype
(FOXA1+SOX17+FOXA2+) (Figure 2C and data not shown).
The optimized culture conditions could also maintain EP lines
generated from 3–4 week liver differentiation cultures as
described in Figure 1 (liver-derived EP cell). These cells dis-
played characteristics similar to those of EP cells derived directly
from definitive endoderm (data not shown).
We were able to derive EP cell lines from the human ESC lines
H9 andCHB8 and from two human iPSC lines (H9-EP, CHB8-EP,
iPS1-EP and iPS2-EP; see Supplemental Experimental Proce-
dures). Endoderm progenitor populations generated from all of
these PSC lines have been maintained for more than 20
passages with an expansion of >1016 while maintaining the
progenitor phenotype (Figure 2C and data not shown). Thus,
self-renewing EP cell lines can be generated reproducibly from
human PSCs. Expansion of EP cells is not associated with
a ‘‘crisis’’ where cells undergo a high rate of senescence as indi-
cated by a transient flattening of the growth curve (Figure 2C).
Moreover, karyotype analyses were performed on EP cells
derived from H9 ESCs and one iPSC line and were found to be
normal (Figure S1 available online). These data indicate that
the high rate of EP cell proliferation is not due to acquired genetic
instability or chromosomal rearrangements. Cryopreserved EP
cells can be thawed with high viability (data not shown).
Among the cytokines used, BMP4 and FGF signaling were the
most critical for EP cell maintenance. Withdrawal of BMP4 led to
an almost complete loss of SOX17 expression within 1 week and
upregulation of PDX1, indicating pancreatic differentiation (Fig-
ure S2A). Withdrawal of bFGF or disruption of the FGF/Ras/
MEK pathway with the small molecule inhibitors PD173074
and PD0325901 reduced proliferation dramatically (Figure S2B),
consistent with previous reports that FGF signaling is essential
for DE expansion (Morrison et al., 2008). Withdrawal of VEGF
or EGF also led to a significant decrease in proliferation (Fig-
ure S2B). TGF-b signaling was also found to be essential for
maintaining the EP cells because treatment with a small
molecule inhibitor of TGF-b signaling, SB431542, completely
abolished SOX17 expression in these cells and drastically
suppressed proliferation (Figures S2C and S2D). The inhibition(D) Quantitative RT-PCR confirmation of a subset of genes examined in (C). Exp
endoderm for primitive streak genes, and EP cells for definitive endoderm genes,
each population.
(E) Flow cytometry analyses distinguish EP cells from ESCs and transient endode
histograms; transient endoderm: red histogram; EP cells: yellow histograms.)
See also Figure S3 and Tables S1–S4.of TGF-b signaling in EP cells also inhibited their differentiation
into pancreatic b-cells, possibly due to spontaneous differentia-
tion prior to pancreatic induction (Figure S2E).
Nine subclones from the H9-EP line were established by
depositing single CXCR4+CD117+ cells into 96-well plates to
expand. These clones displayed the same proliferative capacity
and marker expression as the parental line (data not shown).
Thus, we have established clonal populations of EP cell lines
that exhibit extensive proliferative capacity and express markers
of early multipotent endoderm.
Characterization of EP Cells
We used gene expression microarrays to compare the transcrip-
tomes of purified H9 ESCs, Activin A-induced day 5 transient
endoderm, and H9-EP (Figure 2A) (see Supplemental Experi-
mental Procedures). Cluster analysis of the microarray data
revealed that EP cells are more similar to day 5 transient endo-
derm than they are to ESCs (Figure 3A). Principal component
analysis revealed that while EP cells are more similar to transient
endoderm than they are to ESCs, they are also distinct from
transient endoderm (Figure 3B). As expected, high level ex-
pression of the pluripotency markers NANOG, OCT4, SOX2,
and DNMT3B was limited to ESCs (Figures 3C and 3D). Interest-
ingly, the proto-oncogene MYCN was expressed in both ESCs
and EP cells. MYCN is required for pluripotency and self-renewal
of mouse ESCs (Varlakhanova et al., 2010) and may have a
similar role in EP cells. Genes expressed in the primitive streak
or mesendoderm, including CER1, FGF17, FGF8, GSC, and
MIXL1, are expressed in day 5 transient endoderm, but not EP
cells, while a subset of genes including EOMES and LHX1 are
maintained in both cell types (Figures 3C and 3D). As expected,
expression ofmost endodermal genes including FOXA2, FOXA3,
GATA4, and SOX17 was limited to day 5 endoderm and EP cells
(Figures 3C and 3D).
The microarray data predicted surface markers that may be
used to distinguish EP cells from ESCs and day 5 transient
endoderm (Figure 3C). For example, the ESC marker CD9 was
depleted in EP cells. Messenger RNAs encoding endodermal
markers CXCR4 and CD117 were expressed in both EP cells
and transient endoderm (Figure 3C), confirming our flow cytom-
etry studies (Figure 1 and Figure 2). In contrast, activated leuko-
cyte adhesionmolecule ALCAM/CD166 (Bowen et al., 1995) was
expressed only by EP cells but not day 5 transient endoderm,
while CD177/NB1, a glycoprotein expressed by neutrophils
(Stroncek, 2007), was reduced in EP cells compared to day 5
endoderm (Figure 3C). The stem cell/progenitor markers
CD133, CD34, and LGR5 (Mizrak et al., 2008; Barker et al.,
2010) were also expressed at relatively high levels in EP cells.
Differential expression of a subset of the cell surface markers
predicted by the microarray studies was confirmed by flow cy-
tometry on ESCs, EP cells, and day 5 endoderm, demonstrating
that ALCAM and LGR5 are enriched on EP cells (Figure 3E).ression levels were normalized to 1 in ESCs for pluripotency genes, transient
respectively. Error bars represent the standard error of three individual pools of
rm cells by cell surface markers ALCAM, LGR5, and CXCR4. (ESCs: gray filled
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Table 1. Transcriptional Regulators Enriched in EP Cells
Gene Fold Expression (EP Cell / Transient Endoderm)
GATA3 >103
TBX3 7.83
ID2 8.43
MSX2 8.23
RFX6 83
MEIS2 63
ID1 5.53
SALL1 4.33
HEY2 3.43
FOXP2 3.43
ISL1 3.13
LMO7 3.03
ISX 2.73
Gene expression was analyzed by microarray as described in Figure 3.
The top 13 transcriptional regulators that were enriched in EP cells over
transient definitive endoderm are shown.
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endoderm, yet exhibit key differences in gene expression. The
microarray data were analyzed for transcriptional regulators
that are enriched in EP cells and therefore might confer unique
biological properties to this population. The top 13 hits are
shown in Table 1, along with the fold increase in expression
over day 5 transient endoderm. GATA3, a GATA family member
enriched in mouse DE (Sherwood et al., 2007), ranks first in the
list. HEY2, a target of Notch signaling, is enriched in EP cells,
suggesting a possible role of Notch signaling in EP cell mainte-
nance. Interestingly, transcription factors known to be important
regulators of early liver (TBX3) (Lu¨dtke et al., 2009), pancreas
(ISL1 and RFX6) (Ahlgren et al., 1997; Smith et al., 2010), lung
(FOXP2) (Shu et al., 2001), and intestine (ISX1) (Choi et al.,
2006) were enriched in EP cells, suggesting the capacity to
form these multiple endodermal lineages.
EP Cells Exhibit Multilineage Endodermal
Differentiation In Vitro
We next tested whether expanded EP cells retain the ability
for multipotent endodermal differentiation upon manipulation of
culture conditions. EP cell lines were differentiated under con-
ditions known to promote hepatocyte, pancreatic, or intestinal
specification in vitro (Gouon-Evans et al., 2006; Nostro et al.,
2011; Spence et al., 2011a). For all induction protocols, EP cells
were assumed to be at the DE stage and were stimulated as
such. Representative data are shown for a polyclonal H9-EP
line and two single-cell-derived subclones (Figure 4, Figure 5,
and Figure S4–S6). In addition, hepatocyte and pancreatic differ-
entiation from two iPSC-derived EP cell lines (iPS1-EP and iPS2-
EP) were examined with similar results (Figures S4 and S5).
To induce hepatocyte specification, EP cells were stimulated
using a step-wise protocol adapted from previously published
studies (see Experimental Procedures and Supplemental
Experimental Procedures) (Gouon-Evans et al., 2006; Basma
et al., 2009). Hepatocyte specification was monitored at days
14, 20, and 27 of induction by QRT-PCR and at day 20 by flow376 Cell Stem Cell 10, 371–384, April 6, 2012 ª2012 Elsevier Inc.cytometry. By day 20most cells exhibited features of hepatocyte
morphology including polygonal shape and multinuclearity
(Figure S4A). QRT-PCR analysis revealed upregulation of the
hepatic markers alpha-1-antitrypsin (AAT), alpha-fetoprotein
(AFP), Albumin (ALB), CYP3A4, CYP3A7, and glucose-6-phos-
phatase (G6PC) (Figures 4A and S4B). Intracellular flow cytome-
try at day 20 of differentiation showed that more than 90% of
cells were AFP+ and more than 80% of cells expressed AAT,
indicating commitment to the hepatocyte fate (Figures 4B and
S4C). The mature hepatocyte marker ASGPR1 (Basma et al.,
2009) was expressed on about 20% of the cells while the EP
cell marker CXCR4 was absent (Figure 4B). EP cells generated
from two iPSC lines also differentiated into hepatocytes (Fig-
ure S4B). When treated with Rifampicin, EP cell-derived hepato-
cytes exhibited inducible CYP3A4 activities comparable to
HepG2 cells (Figures 4C and S4D). Thus, EP cells consistently
exhibit hepatocyte potential.
Endoderm components of liver and pancreas are thought to
arise from the putative common foregut precursor (Spence
et al., 2009). To investigate the pancreatic potential of EP cells,
we modified the protocol reported by Nostro et al. (2011) (see
Supplemental Experimental Procedures). Immunofluorescence
analysis of differentiated EP cultures showed colonies that
contain c-peptide+ but no GLUCAGON+ (GCG+) cells as
compared to primary human islets that express both of these
hormones (Figure 5A). Colonies generated from EP cells were
also PDX1+, indicative of pancreatic specification (Figure 5A).
PDX1 expression was confirmed by flow cytometric analyses at
days 10–11 of differentiation in the H9-EP line (not shown),
single-cell derived subclones, and two iPSC-derived EP cell lines
(Figure S5A). In addition, approximately 5%–30% of the differ-
entiated EP cells (H9 and iPSC derived) expressed c-peptide
by day 14 of pancreatic induction (Figures 5B and S5A). The effi-
ciency of c-peptide+ cell generation was variable depending
on the genetic background of the cell line (Figures 5B and S5A).
However, c-peptide+ cells generated from all EP cell lines,
regardless of genetic background, were negative/low for GCG
and SOMATOSTATIN (SST) expression (Figures 5A, 5B, and
S5A). We also examined the differentiation cultures by QRT-
PCR. Consistent with pancreatic differentiation, expression of
PDX1, NKX6-1, and NEUROD1 were strongly induced (Figures
5C and S5C), while the expression of the EP cell marker SOX17
declined (Figure S5C). Transient expression of NEUROG3
(NGN3) in the EP cell differentiation cultures is indicative of endo-
crine specification (Figure S5C). Insulin (INS) RNA was robustly
induced with levels approximately 20% of that found in adult
islets. When these data are corrected for the percentages of
c-peptide+ cells in the samples (islet 60%, H9-EP 15% ± 3%,
H9-EP clone 2 22% ± 4%) (Figure 5C), the levels of INS RNA
in EP cell-derived b-cells are estimated to be 70% of that
found in primary b-cells. This is consistent with protein levels of
c-peptide in primary b-cells and EP cell-derived pancreatic
cells as determined by intracellular flow cytometry (Figure 5E).
Notably, MAFA, a critical transcription factor expressed in
mature b-cells, was upregulated in the EP cell differentiation
cultures (Figure 5C) to 30% of the level of RNA found in adult
islets. If the same correction for INS expression is used, then
both MAFA and NKX6-1 may be expressed in EP cell-derived
c-peptide+ cells at comparable levels to those in adult b-cells.
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Figure 4. Hepatic Differentiation of EP Cells In Vitro
(A–C) Cells from the H9-EP line and from one single-cell-derived subclone (clone 2) were differentiated into hepatocytes as indicated, and were harvested for
analyses at days 14, 20, and 27 (T14, T20, and T27). (A) Gene expression was analyzed by QRT-PCR on samples harvested at three time points from H9-EP and
clone 2 lines, comparing to undifferentiated EP cells (T0). The expression of indicated genes is normalized to the housekeeping gene PPIG. Values represent the
mean of three independent differentiation experiments. Error bars represent the standard error. (B) Flow cytometry analyses of AFP versus FOXA1, AAT versus
FOXA1, or ASGPR1 versus CXCR4 at day 20 of differentiation, comparing to undifferentiated EP cells (T0 EP cell). Percentage of cells within each quadrant is
indicated. Shown are the representative data from H9-EP (passage 10) and clone 2 EP (passage 6) cells. (C) To assess CYP3A4 activity of EP cell-derived
hepatocytes, H9-EP cells (passage 15) were differentiated into hepatocytes for 24 days and then cultured in the presence (Rifampicin) or absence (DMSO) of
Rifampicin for 3 days, and compared to HepG2 cells. Values represent means of measured luminescence units normalized to 6 3 104 cells, and error bars
represent standard error (n = 3). See also Figure S4 and Tables S1–S4.
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Figure 5. Pancreatic Differentiation of EP Cells In Vitro
(A–D) Cells from the H9-EP line (passages 6–12) and from one single-cell-derived subclone (clone 2) (passages 5–11) were differentiated into pancreatic cells
as indicated in the text. Cells were harvested for analyses at day 12 (T12) to day 18. (A) Immunofluorescence staining of human islets (Islet) and day 14 EP
cell-derived pancreatic cultures (EP) for c-peptide (red) and GCG (green) or PDX1 (green). Scale bars represent 100 mm. (B) Intracellular flow cytometric analyses
of c-peptide versus GCG and c-peptide versus SST at day 12 of differentiation. (C) Gene expression was analyzed by QRT-PCR on samples harvested at day 18
of differentiation and compared to adult islets. The expression of indicated genes is normalized to 1 in islets. Values represent the mean of three independent
differentiation experiments or two batches of adult islets. Error bars represent the standard error. (D) The percentage of c-peptide+ cells that coexpress either
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minimal expression of GCG and relatively low expression of
SST (Figures 5B and 5C). This contrasts with the majority of
reports describing the generation of c-peptide+ cells from
human PSCs, in which most pancreatic endocrine progeny
display a polyhormonal phenotype (D’Amour et al., 2006; Nostro
et al., 2011; Rezania et al., 2011). Polyhormonal pancreatic cells
are found during mouse development but do not contribute
to the b-cell population in the adult mouse (Herrera, 2000). In
agreement with this, H9 ESCs exposed to the same pancreatic
differentiation protocol produced a greater proportion of poly-
hormonal cells compared to pancreatic endocrine cells derived
from EP cells (Figure 5D). EP cells generated a c-peptide+ pop-
ulation with less than 2% of the cells coexpressing GCG and
5%of the cells coexpressing SST. In contrast, c-peptide+ cells
generated directly from ESCs were 38% ± 9% GCG+ and
>20% ± 1% SST+ (Figure 5D). Thus, c-peptide+ cells generated
frommultiple EP cell lines are more similar to mature b-cells than
populations generated directly from PSCs.
Previous reports have shown that polyhormonal cells derived
from ESCs are not fully functional and cannot efficiently respond
to glucose stimulation by releasing insulin (D’Amour et al., 2006).
A time course analysis of glucose-induced c-peptide release
was performed, comparing EP cell (H9-EP and iPS2-EP)-derived
pancreatic differentiation cultures to primary human islets (Fig-
ures 5F and S5D). Data were collected over 40 min of stimulation
with 20 mM glucose and was normalized, setting the 5 min
basal stimulation time point for each culture as 1. The kinetics
of c-peptide release was similar between the EP cell-derived
cultures and primary human islets, with a consistent 3-fold
stimulation index in the high glucose group over basal (low
glucose) conditions. EP cell-derived cultures were statistically
indistinguishable from primary islets, with the exception of the
10 min time point. When the cells were challenged again after
3 or 18 hr, they remained responsive to glucose stimulation
in a similar manner as in the first challenge (data not shown), indi-
cating that these cells maintain glucose-responsive function.
Assuming that all of the proinsulin is processed into c-peptide
and insulin is at a 1:1 molar ratio, the c-peptide release assay
revealed an estimated secretion of 9 ± 1.7 ng insulin per 105
EP cell-derived c-peptide+ cells (n = 3), which is 20% of the
secretion of adult islet b-cells (estimated at 37 ng/105 cells, n =
2; and Lukowiak et al., 2001). These findings demonstrate that
EP cell-derived b-cells are functionally responsive to the physio-
logic stimulus (D-glucose) for insulin release in a manner similar
to that of adult islets in vitro.
To compare the differentiation capacities of the EP cells
derived from day 5 transient endoderm and the EP cells derived
from liver differentiation cultures of ESCs, liver-derived EP cellsSST or GCG was quantified. Data are shown for endocrine cells generated fro
(ESC, n = 4).
(E) Intracellular flow cytometric analyses of c-peptide expression, gated on c-pe
and from human islets (red filled histogram). The values shown are mean fluoresce
(red, n = 2).
(F) The H9 EP cells were differentiated into b-cells and stimulated with D-glucose a
C-peptide release was measured at various time points (5, 10, 15, 20, and 40 mi
indicates statistical significance as determined by t test. p = 0.022.
See also Figures S5 and Tables S1–S4.were allowed to differentiate in the aforementioned liver or pan-
creas conditions. These cells generated hepatocyte progenitors
that expressed AFP and AAT (Figure S4C) and pancreatic cells
that expressed PDX1 and c-peptide, but not GCG (Figure S5A,
bottom panel), with efficiencies similar to the EP cells derived
from transient endoderm. These data suggest that EP cells
are a robust stem cell population that can be generated from
multiple stages of differentiation while maintaining multipotency.
Liver and pancreas are of foregut origin. We next determined
whether EP cells could produce intestinal epithelia, which arises
from mid/hindgut regions. Using a protocol similar to that of
Spence et al. (2011a), we induced EP cells to undergo intestinal
differentiation (see Supplemental Experimental Procedures).
Typical ‘‘organoids’’ indicative of intestinal differentiation were
identified upon day 30 of induction (Figure S6A). These cultures
expressed CDX2 and KLF5, transcription factors enriched in
mid/hindgut lineages (Spence et al., 2011a), and the Paneth
cell marker Lysozyme (LYZ) (Figure S6B). In contrast, the intes-
tinal stem cell marker LGR5, which is also expressed on EP cells,
was downregulated after 30 days of induction to levels similar
to those in adult intestine. Intracellular flow cytometric analysis
revealed that 85%–90% of cells expressed CDX2 at day 30 of
differentiation, similar to the intestinal tumor cell line CACO-2
(Figure S6C). These data suggest that EP cells have intestinal
potential.
To determine if EP cell developmental potential was
restricted to endodermal lineages, cultures were induced with
conditions established to drive ESCs toward either neuroecto-
derm (Greber et al., 2011) or mesoderm (J.M., L.Y., and X.C.,
unpublished data) (see Supplemental Experimental Proce-
dures). The upregulation of neuroectoderm markers ZIC1,
SOX1, or PAX4 (Figure S3A), and mesoderm markers MIXL1,
T, or PECAM (Figure S3B), was not observed, suggesting that
EP cells are committed to the endoderm germ layer.
EP Cells Lack Tumorigenicity and Form Endodermal
Tissues In Vivo
The propensity for ESCs and iPSCs to form teratomas repre-
sents a major impediment to transplantation studies. To deter-
mine if EP cells retain tumor-forming potential, 0.5 million H9
ESCs or H9-EPs were transplanted intramuscularly into
immune-compromised mice. After 4–6 weeks, all mice injected
with H9 ESCs developed tumors, while mice injected with an
equal number of EP cells did not (Figure 6A). In fact, it was diffi-
cult to detect any injected EP cells under these conditions.
Therefore, larger numbers (8 to 103106) of EP cells were trans-
planted in concentrated matrigel containing growth factors to
promote cell survival and recruit host blood vessels (see Exper-
imental Procedures). Under these conditions, no EP cell-derivedm EP cells (H9-EP, n = 12; and iPS2-EP, n = 5) and directly from H9 ESCs
ptide+ cells from day 12 EP cell-derived pancreatic cultures (blue histogram)
nce intensity of c-peptide in H9-EP-derived cells (blue, n = 6) and human islets
t 2mM (Basal) or 20mM (glucose) at day 14, and were compared to adult islets.
n) (H9-EP, n = 3; islets, n = 2; error bars represent the standard error). Asterisk
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Figure 6. Tumor Potential and Spontaneous Differentiation of EP cells In Vivo
(A) To determine if EP cells retain teratoma forming potential, 0.5 million H9 ESCs or H9 EP cells were transplanted intramuscularly into immune compromised
mice. Images show teratoma formation in a mouse injected with ESCs (ES, left panel) and lack of tumor formation in a mouse injected with EP cells (EP,
right panel).
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of 3–60 weeks. In contrast, when the cells from day 5 transient
endoderm differentiation cultures of ESCs were transplanted in
this system, all animals developed teratomas. Surprisingly,
even purified CXCR4+CD117+ DE cells isolated by cell sorting
from day 5 ESC differentiation cultures still generated tumors
within 6 weeks of transplantation (Figure 6B). It is possible that
CXCR4+CD117+ DE cells may not be fully committed to endo-
derm and still retain teratoma-forming ability, or that a small
number of contaminating ESCs present even after cell sorting
led to tumor formation. In addition, when the cells from day 20
liver differentiation cultures of ESCs were transplanted, four
out of five animals still developed teratomas (Figure 6B). These
data indicate that EP cells are less tumorigenic than ESCs,
iPSCs, transient endoderm, and ESC-derived hepatic cultures.
Next, we examined transplanted matrigel-EP cell plugs for
evidence of cellular differentiation. By 3–8 weeks after transplan-
tation, cells formed various endodermal tissues, ranging from
epithelium-forming cysts and tubes that appear similar to early
gut tube endoderm (Figure 6C, top panels) to larger, more
complex structures containing differentiated cells (Figure 6C,
bottom panels; and data not shown). These included intestinal-
like structures with epithelial cells surrounding a central lumen
(Figure 6C, bottom panels) and hepatoblast-like structures
(data not shown). Staining with a pantissue human-specific anti-
body demonstrated that these endodermal structures arose
from the transplanted EP cells, in contrast to surrounding fat
and mesenchyme, which was murine host derived (Figure 6D).
Immunohistochemistry with human-specific antibodies was
used to further characterize the developmental potential of
transplanted EP cells. All EP cell-derived morphologically endo-
dermal structures expressed FOXA1 and FOXA2, consistent with
an endodermal origin (Figure 6E and data not shown). The struc-
tures resembling intestinal epithelia expressed the transcription
factors HNF4A and CDX2, key regulators of intestinal homeo-
stasis (Spence et al., 2011b). These cells also stained for the
intestinal epithelial markers human fatty acid binding protein
(IFABP), VILLIN1, and MUCIN2 (Figure 6E). In addition, immuno-
histochemistry revealed that the hepatoblast/hepatocyte-like
structures harbor cells positive for AFP and AAT (Figure 6F).
These data clearly demonstrate that EP cells are able to differen-
tiate into gut epithelia and liver in vivo.
DISCUSSION
The ability to generate stem cell lines that self-renew in vitro and
differentiate into various mature tissues after manipulation of
culture conditions or transplantation into animals has revolution-
ized biology and offers great promise for medical applications.(B) A summary of teratoma-forming ability of pluripotent stem cells (ES/iPSC
(ES-derived hepatocytes), and EP cells (EPC) and EP cell-derived day 9 hepatoc
cultures and CXCR4+CD117high sorted cells were used for transplantation.
(C–F) Analyses of EP cell transplants. Eight to ten million EP cells mixed with matri
matrigel plugs were isolated 3–12 weeks posttransplantation. Scale bars repres
eosin. Shown are endoderm-like structures at lower (103, left panel) and higher m
antibody reveals human-cell-derived endodermal structures surrounded by non
markers reveals gut/intestinal structures in the matrigel plug. (F) Immunohistoch
See also Figure S6 and Tables S1–S3.In this regard, it is likely that different stem cell lines with distinct
developmental potentials will be exploited for unique applica-
tions. For example, ESCs, trophectoderm stem cells (TSCs),
and extraembryonic endoderm stem cells (XENCs), generated
from three distinct cell types of the mouse blastocyst, display
developmental potentials similar to those of their respective
progenitors (Tanaka et al., 1998; Kunath et al., 2005). Here we
describe the establishment of continuously replicating, clonal
endoderm-committed stem cell lines from human ESCs and
iPSCs. These cells, termed EP cells, can self-renew and specif-
ically generate endodermal lineages from both the foregut and
mid/hindgut.
EP cells exhibit several unique features in comparison to other
endodermal progenitors previously reported. Hepatocyte stem
cell populations can be derived from adult liver (Schmelzer
et al., 2006). In addition, a possible hepatic stem cell population
was generated from human ESCs (Zhao et al., 2009). These two
cell types differentiate into liver lineages only, in contrast to the
more broad developmental potential exhibited by EP cells.
Another report indicates that SOX17 overexpression in human
ESCs generates a progenitor population that expresses genes
indicative of both ESCs and endoderm and can differentiate
into endoderm derivatives (Se´guin et al., 2008). These cells
express ESC markers such as OCT4 and NANOG and are not
endoderm-committed because they generate mesoderm-
containing teratomas. A cell population similar to EP cells but
derived from mouse ESCs has been reported (Morrison et al.,
2008). Perhaps themost distinguishing feature of human EP cells
described here is their extensive proliferative capacity. Mouse
endoderm progenitors were only reported to expand 2,000-
fold in culture (Morrison et al., 2008), whereas human EP cells
exhibit virtually unlimited self-renewal (>1016) (Figure 2 and
data not shown). In contrast to the current study, mouse EP cells
were not analyzed at the clonal level and were tested only for
hepatic and pancreatic development and may therefore be
restricted in developmental potential. In addition, EP cells can
be maintained as a homogenous SOX17+FOXA1+ undifferenti-
ated cell population. This is a critical point because partially
differentiated EP cell cultures (see Figure 1 and Figure 2A) cannot
be reproducibly differentiated into either hepatocytes or b-cells
at the efficiencies reported here, starting with pure undifferenti-
ated EP cultures (data not shown and Figure 5 and Figure 6).
This is a well-known phenomenon also seen with directed differ-
entiation of ESCs and may be due to the inability of partially
differentiated cells to be respecified down a different develop-
mental path. It will be important to systematically compare the
proliferative and developmental capacities of EP cells to various
other endoderm progenitor populations in order to better define
their biological features and utility for downstream applications.), day 5 (T5) transient endoderm, ESC-derived day 20 hepatocyte cultures
yte cultures (EP cell-derived hepatocytes). For transient endoderm, both bulk
gel were injected subcutaneously into immunodeficient mice, and the resultant
ent 100 mm. (C) Sections of matrigel plugs were stained with hematoxylin and
agnifications (203, right panel). (D) Immunohistochemistry using an anti-human
human mesenchyme and adipocytes. (E) Immunohistochemistry for intestinal
emistry for hepatocyte markers in the matrigel plug.
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hormonal insulin-expressing cells in vitro is promising (Figure 5).
Most attempts to generate functional b-cells from human
PSCs in culture have failed to generate glucose-responsive
cells (D’Amour et al., 2006; Nostro et al., 2011). Those studies
that have reported glucose responsiveness have low levels of
c-peptide+ cells, have not carefully examined the percentage
of cells in a population with the abnormal polyhormonal pheno-
type (Jiang et al., 2007; Zhang et al., 2009; Thatava et al.,
2011), or have some combination thereof. It will be important in
the future to compare b-cells generated using different method-
ologies to determine which generates the most robust functional
cell type. In agreement with these prior studies, we also found
that human ESCs stimulated to undergo pancreatic differentia-
tion produce polyhormonal b-cells (data not shown and Fig-
ure 5D). It is possible that production of functionally superior
b-cells from EP cells reflects biological features related to
the developmental timing of pancreatic endoderm production
in vivo. During normal human embryogenesis, b-cells are
not generated until 10 weeks after endoderm specification
(Spence and Wells, 2007), while in ESC differentiation cultures
this typically occurs in 2 weeks (D’Amour et al., 2006). It is
possible that this accelerated timeframe in ESC differentiation
cultures precludes the establishment of essential transcriptional
networks and/or epigenetic modifications required for proper
b-cell formation. Further analysis and comparison of ESC endo-
derm and EP cell differentiation cultures may reveal specific
genes and epigenetic modifiers that regulate optimal formation
of functional b-cells.
Our experiments indicate that EP cells lack intrinsicmesoderm
and ectodermal potential. Directed differentiation protocols
developed for mesoderm or ectoderm were unable to induce
gene expression profiles specific to these lineages when applied
to EP cells, suggesting an endoderm-restricted program (Fig-
ure S3). Moreover, in vivo transplanted EP cells exclusively
generate endodermal structures that stained with a human-
specific antibody (Figure 6D). In addition, pathological analysis
of 24 independent transplants did not detect any morphologi-
cally ectodermal tissues (data not shown). This lineage restric-
tion makes EP cells a powerful platform to dissect the signals
necessary for the specification of endodermal cell types.
Flow cytometry and microarray analyses reveal a unique gene
expression pattern in human EP cells, distinct from undifferenti-
ated ESCs or CXCR4+CD117+ transient endoderm. LHX1 and
EOMES, while not typically defined as mature gut tube markers,
are maintained in EP cells (Figure 3). This raises the possibility
that these transcription factors may play a role in EP cell fate
or self-renewal. These data along with the expression of markers
typical of cells undergoing specification of various endodermal
lineages (Table 1) suggest that EP cells are not gut tube
endoderm ‘‘frozen in time,’’ but are a distinct in vitro stem cell
population. Investigation of these differences could identify key
regulators of endoderm maintenance and development.
In summary, we describe a simple culture procedure to repro-
ducibly and efficiently generate endoderm stem cell lines from
human PSCs. Resultant EP cells self-renew rapidly and can be
stimulated to form hepatic, pancreatic, and intestinal tissues.
Moreover, EP cells are nontumorigenic, reflecting their potential
utility for tissue replacement therapies. Our work challenges the382 Cell Stem Cell 10, 371–384, April 6, 2012 ª2012 Elsevier Inc.notion that ESCs/iPSCs must be used as a starting point for
directed tissue differentiation studies. Rather, EP cells serve as
an intermediate between iPSCs/ESCs and mature endodermal
derivatives. The ability to generate functional monohormonal
b-cells from iPSCs will enable in vitro modeling of diseases
of the b-cell, including multiple genetic forms of diabetes and
hyperinsulinemias. These lines will provide innovative experi-
mental platforms to investigate mechanisms of endodermal
differentiation and a safer, more efficient starting point for tissue
replacement therapies aimed at common human disorders
including liver failure and diabetes.
EXPERIMENTAL PROCEDURES
Human PSC Culture and Differentiation
Human ESC lines H9 and CHB8 were obtained from the National Stem Cell
Bank and Massachusetts Human Stem Cell Bank, respectively. The human
iPSC lines iPSC1 (CHOP_WT1.2) and iPSC2 (CHOP_WT2.2) were derived
from wild-type human fibroblasts (J.M., L.Y., and X.C., unpublished data,
and see Supplemental Experimental Procedures). For generating day 5 tran-
sient endoderm cells, human PSCs were differentiated in the serum free differ-
entiation (SFD) media (Gadue et al., 2006) as either embryoid bodies (EBs)
(Gouon-Evans et al., 2006) or monolayer cultures (D’Amour et al., 2006; Nostro
et al., 2011). Further details are described in the Supplemental Experimental
Procedures.
Establishment and Maintenance of EP Cell Lines
EP cells were first purified fromday 27 hepatocyte differentiation cultures of H9
ESCs by sorting for CXCR4+/CD117high cells and culturing them in hepatic
induction media on matrigel (BD Biosciences) with mouse embryonic feeder
(MEF) cells. The optimal culture conditions for maintaining EP cells were
established by culturing cells on growth-factor-reduced matrigel and MEF
cells ([0.5 3 106]/58 cm2) and eliminating cytokines that promote hepatocyte
differentiation. This medium is composed of SFD-based media supplemented
with BMP4 (50 ng/ml), bFGF (10 ng/ml), VEGF (10 ng/ml), and EGF (10 ng/ml)
(see more details in Supplemental Experimental Procedures). EP cells from
other PCS lines were established from day 5 transient endoderm by sorting
for CXCR4+/CD117high cells and maintaining them as described above in
a 5% CO2, 5% O2, 90% N2 environment.
Differentiation of EP Cells
The hepatic, pancreatic, and intestinal in vitro differentiation protocols
were adapted from previously published reports (Gouon-Evans et al., 2006;
Nostro et al., 2011; Spence et al., 2011a). Detailed protocols can be found in
Supplemental Experimental Procedures.
Teratoma/Transplantation Assay
For the intramuscular injection, 0.5 3 106 H9 ESCs or EP cells were dissoci-
ated, mixed with 250 ml matrigel, and transplanted intramuscularly into the
leg of SCID/Beige immunodeficient mice. Teratoma formation was monitored
over a period of 4–8 weeks. In the following experiments, 5 to 10 3 106 cells
were embedded in 300 ml high-concentration matrigel (BD Biosciences) that
was supplemented with a combination of cytokines (see details in Supple-
mental Experimental Procedures), and they were injected subcutaneously
into the neck of SCID/Beige mice. Teratoma formation was monitored over
a period of 3–60 weeks. Resultant matrigel plugs/transplants were surgically
removed from the mice, fixed in 10% formaldehyde, embedded in paraffin,
and analyzed using hematoxylin and eosin stains for morphology or immuno-
histochemistry for specific antigens as described in Supplemental Experi-
mental Procedures. All animal work was approved by the institutional IACUC
committee.
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